Skip to main content
Clinical Trials/IRCT20160523028008N23
IRCT20160523028008N23
Recruiting
Phase 2

Comparison of efficacy and safety of Levetiracetam and Phenobarbital in controlling neonatal seizures

Hamedan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hamedan University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Gestational age of 36 weeks or more
  • Weighing 2 kg or more
  • Occurrence of neonatal seizures between the first day and the 28th day after birth
  • Consent of the baby's parents or legal guardian

Exclusion Criteria

  • Receiving anti convulsion drugs in the last 72 hours
  • Seizures due to hypocalcemia, hypoglycemia, hypomagnesemia, and other electrolyte disorders
  • Serum creatinine level greater than 1\.6 mg / d

Outcomes

Primary Outcomes

Not specified

Similar Trials